Thermo Fisher Scientific (TMO) Net Cash Flow (2009 - 2026)

Thermo Fisher Scientific has reported Net Cash Flow for 18 years, with the latest figure at $718.0 million in Q2 2026.

• Net Cash Flow for Q2 2026 came in at $718.0 million, up 498.33% year-over-year; the trailing twelve-month figure through Jun 2026 was -$600.0 million (up 78.13% YoY), and the FY2025 annual result was $5.6 billion, up 240.49% from the prior year.
• Net Cash Flow climbed to $718.0 million in Q2 2026, from -$6.7 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $7.9 billion in Q4 2025 and troughed at -$6.7 billion in Q1 2026.
• A 5-year average of -$29.2 million and a median of -$131.0 million in 2024 frame the typical range for Net Cash Flow.
• The widest annual swing landed in 2025, when Net Cash Flow surged 2311.8%; it then plunged 7202.13% in 2026.
• A 5-year view of Net Cash Flow shows it stood at $5.4 billion in 2022, then slumped by 64.15% to $1.9 billion in 2023, then sank by 118.55% to -$356.0 million in 2024, then surged by 2311.8% to $7.9 billion in 2025, then sank by 90.88% to $718.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $718.0 million in Q2 2026, -$6.7 billion in Q1 2026, and $7.9 billion in Q4 2025.